
Broadline leads financing in EndoSphere Inc
EndoSphere Inc, a medical technology company developing a platform of endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes, has completed a highly oversubscribed Series A Preferred Financing round led by private equity firm Broadline Capital. EndoSphere Inc., which holds 23 US and international

